Japan Re-approves Thalidomide For Cancer Treatment

TOKYO - Japan's Ministry of Health, Labor and Welfare has approved re-listing thalidomide, which Japan banned in 1962 for causing serious human deformations, to be marketed by Fujimoto Pharmaceutical, officials of the ministry's Pharmaceutical and Food Bureau and the Insurance Bureau confirmed Oct. 7